Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Keep a log of your symptoms and blood sugar readings to share with your healthcare provider
The FDA has approved semaglutide for two distinct indications: treating patients with type 2 diabetes (under the brand name Ozempic ) and chronic weight management (under the brand name Wegovy )
GLP-1 agonists are synthetic analogues of the incretin hormone GLP-1, engineered to resist enzymatic breakdown by DPP-4 and prolong therapeutic activity
What people are saying 4.5 average across verified Trifecta customers Trifecta Meal Delivery Explained Ready to Eat Meals Our portion perfect meals are fully prepared and delivered to you weekly
Published Phase 2 and Phase 3 trials for both molecules enrol as monotherapy (with or without background T2D therapy such as metformin or insulin)
US$ 22.32
US$ 25.89
US$ 27.58
US$ 28.16
US$ 21.79
